Try our Advanced Search for more refined results

Fresenius' Hits Akorn With Counterclaims Alleging Fraud

By Dave Simpson (May 2, 2018, 10:53 PM EDT) -- Fresenius Kabi AG responded to Akorn Pharmaceuticals Inc.'s lawsuit over their failed filed $4.75 billion merger in counterclaims filed Tuesday in Delaware Chancery Court, saying it discovered that Akorn had attempted to defraud the U.S. Food and Drug Administration in the months before pulling the plug on the merger....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!